business

BioNTech to cut fifth of workforce as it winds down Covid vaccine production

Financial Times•May 5, 20261 min

BioNTech to cut fifth of workforce as it winds down Covid vaccine production Subscribe to unlock this article Try unlimited access Only €1 for 4 weeksThen €69 per month. Complete digital access to quality FT journalism on any device. Cancel anytime during your trial. Explore more offers. Explore our full range of subscriptions. For individuals Discover all the plans currently available in your country

Read the original article →

BioNTech to cut fifth of workforce as it winds down Covid vaccine production

Related Stories

As Vedanta Group posts record FY26 earnings, Chairman Anil Agarwal lays out vision for a ‘very exciting new chapter’

Hero MotoCorp Q4 Results: Profit jumps 30% YoY to Rs 1401 crore; Rs 75 per share dividend declared

Plea in SC alleges fake citations in NCLT order on Essel insolvency

Poonawalla Fincorp Q4 results: Profit jumps 70% QoQ to Rs 255 crore

Aadhar Housing Finance Q4 profit surges 27% to Rs 311 crore on strong growth and expansion

Popular Topics

BioNTech to cut fifth of workforce as it winds down Covid vaccine production

Read the original article

Related Stories

As Vedanta Group posts record FY26 earnings, Chairman Anil Agarwal lays out vision for a ‘very exciting new chapter’

Hero MotoCorp Q4 Results: Profit jumps 30% YoY to Rs 1401 crore; Rs 75 per share dividend declared

Plea in SC alleges fake citations in NCLT order on Essel insolvency

Poonawalla Fincorp Q4 results: Profit jumps 70% QoQ to Rs 255 crore

Aadhar Housing Finance Q4 profit surges 27% to Rs 311 crore on strong growth and expansion

Popular Topics

🔔 Never Miss a Story